Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints CEO

Jamie Macdonald succeeds co-founder Josef von Rickenbach

Jamie MacdonaldBiopharmaceutical services provider, Parexel, has appointed Jamie Macdonald as its chief executive officer (CEO), a role that will see him succeed Josef von Rickenbach.

Macdonald previously led INC Research, now known as Syneos Health, for several years first as CEO and most recently as vice chairman.

He has also served as senior vice president and head of global project management at Quintiles, now IQVIA.

Macdonald said: “As a trail blazer in the biopharmaceutical services industry, the company enjoys well-deserved recognition as having the kind of deep therapeutic and functional expertise, global reach and innovative capability to continue its leadership.

“I am humbled to have the opportunity to build on this legacy and look forward to continued growth and excellence for Parexel.”

20th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics